AptarGroup, Inc.

Valuation Analysis

About the Company

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and cont

AptarGroup, Inc. Stock at a Glance

AptarGroup, Inc. (ATR) is currently trading at $117.72 with a market capitalization of $7.5B. The trailing P/E ratio stands at 20.16x, with a forward P/E of 18.77x. The 52-week range spans from $103.23 to $164.28; the current price is 28.3% below the yearly high. Year-over-year revenue growth stands at +10.8%. The net profit margin stands at 9.98%.

💰 Dividend

AptarGroup, Inc. pays an annual dividend of $1.89 per share, representing a yield of 1.61%. The payout ratio stands at 31.85%.

📊 Analyst Rating

7 analysts rate AptarGroup, Inc. (ATR) on consensus: Buy. The average price target is $160.43, implying +36.28% from the current price. Analyst price targets range from $140.00 to $220.00.

AptarGroup, Inc.: The Investment Case in Detail

AptarGroup, Inc. (ATR) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 10.8% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 36.28% upside from current levels — analyst sentiment is firmly constructive.

What to Watch Next

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 36.28% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy AptarGroup, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.